Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

IGM Biosciences Q2 EPS $(1.16) Down From $(0.62) YoY

IGM Biosciences (NASDAQ:IGMS) reported quarterly losses of $(1.16) per share. This is a 87.1 percent decrease over losses of $(0.62) per share from the same period last year.

byBenzinga Newsdesk

August 9, 2021

1 minute read

IGM Biosciences (NASDAQ:IGMS) reported quarterly losses of $(1.16) per share. This is a 87.1 percent decrease over losses of $(0.62) per share from the same period last year.

Tesla Q1 Deliveries Climb To A Record As EV Maker Weathers Challenges; Model 3/Y Sales Show Weakness

By Shanthi Rexaline

Today, 11:25 PM

Tesla, Inc. (NASDAQ: TSLA) reported strong deliveries for the first quarter, defying the engulfing macroeconomic and geopolitical risks.

Vericel Q1 2022 Earnings Conference Call On May 4, 2022 At 08:30 AM ET

By Benzinga Insights

Today, 11:25 PM

Vericel (NASDAQ:VCEL) will host a conference call at 08:30 AM ET on May 4, 2022, to discuss Q1 2022 earnings results. How to Attend Vericel (VCEL) Conference Call Follow this link to access the live webcast.

VCEL